A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP
A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP

Moderna coronavirus vaccine safe, induces immune response, early results show

  • No serious side effects among volunteers tested, but more than half reported mild or moderate reactions such as fatigue, headache, chills or muscle aches
  • US company was first to start human testing of vaccine candidate on March 16. It will start phase 3 trials with 30,000 volunteers on July 27

Topic |   Coronavirus pandemic
A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP
A subject receives a shot in the first-stage safety study clinical trial of Moderna’s potential vaccine in Seattle in March. Photo: AP
READ FULL ARTICLE